May 22, 2017

3rd International Conference on Central Nervous System Disorders & Therapeutics

IndiaProduction

IndiaProduction

Recommended Reports

3rd World Congress on Controversies in Ophthalmology 2012 - Post-Conference Review and Analysis

Toll Like Receptor 3 (CD283 or TLR3) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2012

Ataxin 3 (Machado Joseph Disease Protein 1 or Spinocerebellar Ataxia Type 3 Protein or SCA3 or ATXN3 or EC 3.4.19.12) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

View All

More

Medical Technology UK 2023

International congress on pediatrics neonatal and nursing care, Prague

Outsourcing in Clinical Trials: Medical Devices USA 2023

Outsourcing in Clinical Trials West Coast (& device stream) 2023